Episoder
-
About Ken Washington:
Ken Washington brings over three decades of experience in leading technical endeavors for Fortune 100 companies, government contractors, and research laboratories. His leadership roles have involved team-building and shaping strategic visions for large organizations. Notably, he was honored as the 2012 Black Engineer of the Year in Research Leadership and later inducted into both the National Academy of Engineers and the Black Engineers Hall of Fame.
Currently serving as the Senior Vice President and Chief Technology & Innovation Officer at Medtronic, Ken also holds board positions at McKesson Corporation and SAE International, where he serves as the Automotive Sector VP. He's been a pivotal member of the Internet Ecosystem Innovation Committee and actively engages in strategic collaborations with universities, notably as a member of the Georgia Tech Advisory Board and former chair of the University of Michigan Leadership Advisory Board.
Ken's expertise spans diverse domains, from automotive research and space science to information privacy and high-performance computing technologies. He excels in program and project management, guiding new facility projects, and fostering collaborative system development. His track record includes successful executive-level presentations, business plan developments, and resource optimization strategies, making him a sought-after leader in both the public and private sectors.
Things You’ll Learn:
Robotics in surgery enhance precision, consistency, and ergonomics, ultimately improving patient outcomes.AI revolutionizes surgery with personalized pre-procedure planning and real-time guidance for surgeons.The future of surgery lies in the combination of robotics, AI, and digital platforms for personalized care.AI algorithms guide surgeons during surgery, enhancing accuracy and precision in procedures.Medtronic is committed to the future of surgery and healthcare with robotics and AI technologies.Resources:
Connect with and follow Ken on LinkedIn.Learn more about Medtronic on their LinkedIn and website. -
The US scores low on healthcare quality compared to other developed countries due in large part to inequities in the system.
But how do we address the needs of underserved communities and improve outcomes for BIPOC populations?
And what do we do when the data doesn’t tell the whole story?
Jackie Ejuwa is Vice President of Health Transformation at Blue Shield of California, where she leads piloting, evaluation and scaling of new and innovative strategies in support of Blue Shield’s Health Reimagined strategy.
A healthcare futurist with a master’s in healthcare leadership, Jackie brings her deep and varied experience in the industry to her role as a health equity champion.
On this episode of The Beat, Jackie joins hosts Dr. Jessica Shepherd and Dr. Gautam Gulati to explain what’s behind the health disparities in underserved populations.
Jackie shares how she makes decisions around where to start working toward health equity, discussing Blue Shield of California’s most successful programs to address SDOH in underserved communities.
Listen in for Jackie’s insight on recognizing when the data is mismatched from reality and learn how to leverage data-informed decision making to work toward health equity.
Topics Covered
Jackie’s role as VP of Health Transformation at Blue Shield of CaliforniaWhy the US scores low on healthcare quality compared to other developed countriesTop contributing factors to health disparities in underserved populationsHow Jackie makes decisions re: where to start working toward health equityStrategies for building trust between underserved communities and health professionalsSeeing data from multiple perspectives when it seems mismatched from realityHow to imbed health equity in operations across a health organizationJackie’s most successful pilot programs to address SDOH and reduce health disparitiesImprovements in culturally inclusive dietary recommendationsWhat’s behind the lack of awareness around colon cancer in BIPOC communitiesShifting the medical education process to expand cultural competenceConnect with Jackie Ejuwa
Blue Shield of CaliforniaJackie at Blue Shield of CaliforniaJackie on LinkedInConnect with Dr. Gautam Gulati & Dr. Jessica Shepherd
ViVEHLTHDr. Shepherd on TwitterDr. Shepherd on LinkedInDr. Gulati on TwitterDr. Gulati on LinkedInResources
Cafecito, Cumbia and SaludCalifornia Assembly Bill 904 -
Mangler du episoder?
-
About Steve Cagle:
Steve Cagle is CEO and a board member of Clearwater, a leading cybersecurity and compliance partner to organizations across the healthcare ecosystem. He assumed the CEO position at Clearwater in May 2018, bringing extensive experience leading, innovating, and scaling healthcare and technology businesses, including having guided a number of companies through critical transformation periods.
Formerly, Mr. Cagle was president and CEO of Moberg Pharma North America, a subsidiary of Moberg Pharma AB (OMX:MOB), a publicly traded Swedish pharmaceutical company. Prior to its acquisition by Moberg AB, Mr. Cagle was president and CEO of Alterna LLC, a consumer healthcare products company.
Prior to joining Alterna, Mr. Cagle was a principal and executive team member of Sparta Systems, Inc., a software company that provides enterprise quality and compliance management software to pharmaceutical and medical device companies. During his nine-year tenure with the company, he served in numerous leadership positions, including marketing, sales, operations, and product innovation, and was responsible for sales and marketing programs, which contributed to Sparta’s leadership position in the pharmaceutical and medical device industries and to its 100-fold sales growth.
Mr. Cagle serves as the executive chairman of CMP Pharma, and he has guided its transformation to an institutionally owned specialty pharmaceutical company. He also serves on the board of the Association of Executives in Healthcare Information Security, one of the leading organizations advancing cybersecurity best practices across the industry. Mr. Cagle holds a Master of Business Administration from New York University's Leonard N. Stern School of Business and a Bachelor of Science degree in finance from Rutgers Business School in New Brunswick, N.J.
Things You’ll Learn:
Cyberattacks are not just about data; they can disrupt critical healthcare services.Establishing a culture of cybersecurity is essential, with boards and executives being accountable.The healthcare ecosystem requires a shared responsibility for cybersecurity.Continuous risk analysis is essential to ensure organizations remain secure amid evolving threats.Federal initiatives, like the HHS cybersecurity strategy, indicate an increased focus on healthcare cybersecurity.Resources:
Connect with and follow Steve on LinkedIn.Learn more about Clearwater on their LinkedIn and website. -
About Syam Adusumilli:
Syam is a seasoned healthcare leader and strategist, with deep product and strategy expertise across all business lines in Healthcare Payor Organizations. He has deep expertise in cutting-edge technologies, including Data Science and AI, Blockchain, Medical IOT, Voice Biometrics, Computational Epidemiology, Digital Therapeutics, Human Centric Design, Behavioral Nudge, and Care Plan Personalization. Syam has 30+ years of experience in technology and business strategy in healthcare, especially when it comes to managing IT operations, defining vision, strategic planning, partner ecosystems, and product engineering and management in the payor domain. He is seasoned in transforming organizations and driving innovations by leveraging digital and AI. As the current Chief Strategy Officer for GroundGame.Health, he is focused on go-to-market strategy, overall business strategy, and public policy. He is a Masters in Public Health candidate at Brown University and was previously the Chief Transformation Officer for Healthcare at UST Global. He serves as a mentor for several startups in HealthTech and beyond in the US, Israel, and India.
Things You’ll Learn:
Digital transformation in healthcare is about focusing on the underserved population, bridging the gap in digital literacy, and addressing unmet needs.Technology should be a tool to empower social workers and community organizations, not replace human connection and empathy.Predictive AI should target the root causes of healthcare issues, not merely treat symptoms.Interoperability is crucial for providing comprehensive care, ensuring healthcare providers have access to patient's social and economic contexts.Empowering community-based organizations with technology and unrestricted funds has the potential to drive impactful change in underserved communities.Resources:
Connect with and follow Syam on LinkedIn.Learn more about GroundGame Health on their LinkedIn and website. -
How do you know if a particular medicine is working?
Traditionally, it takes guesswork on the physician’s part and time to find a drug that works for any given patient.
But what if we could leverage digital biomarkers to measure the efficacy of a medication very quickly and course correct as needed?
Rich Carter serves as Chief Digital Officer at Eli Lilly, where he oversees the teams focused on innovation, user-centered design and digital health.
On this episode of The Beat, Rich joins hosts Dr. Jessica Shepherd and Dr. Gautam Gulati to discuss the future of drug development and clinical trials.
Rich describes what digital transformation means in the context of life sciences, explaining how technology can improve drug discovery and accelerate the timeline from discovery to market.
Listen in for examples of the 35 digital biomarkers in development at Lilly and learn how Rich’s team thinks about partnering with both physicians and patients to roll out these new digital resources.
Topics Covered
3 elements of Rich’s role at Lilly—innovation, design and digital healthWhat digital transformation means in the context of life sciencesHow Lilly Direct is working to simplify the patient experienceWhat we do historically in life sciences that doesn’t make sense anymore (given the technology we have today)The potential for AI to remove bias in the drug discovery spaceRich’s insight on accelerating the discovery-to-market process in life sciencesHow Rich’s team uses ‘old data’ to train predictive AI models and why access to data is one of the biggest challenges in life sciencesUsing digital biomarkers to measure the efficacy of a medicine with diverse populationsHow Rich is inspired by the impact his work has on familiesThe 35 biomarkers in different stages of development at Lilly and what that process look likeHow Lilly’s internal incubation lab partners with other innovators in the healthcare ecosystemPartnering with both patients and physicians to roll out digital resourcesConnect with Rich Carter
Eli LillyRich on LinkedInConnect with Dr. Gautam Gulati & Dr. Jessica Shepherd
ViVEHLTHDr. Shepherd on TwitterDr. Shepherd on LinkedInDr. Gulati on TwitterDr. Gulati on LinkedInResources
Lilly Direct -
About Mary Varghese Presti:
As GM of Dragon Medical, an AI-powered voice assistant used by clinicians to document in the EHR, Mary Varghese Presti leads the development of AI-based clinical workflows for Microsoft Healthcare & Life Sciences. Mary is a seasoned healthcare executive whose career spans nursing, policy, pharma, and tech.
Things You’ll Learn:
How the influx of new nurses due to the pandemic was followed by burnout, leading many to leave the profession.Why the development of AI solutions tailored to nurses’ specific needs should focus on hands-free, eyes-free documentation, allowing nurses to prioritize patient care, personalized to their workflow.How exciting technological innovations like virtual nursing and AI promise significant improvements in patient care and outcomes by transforming care delivery, supporting providers, and enhancing the patient experience.Why it’s important to ensure that nursing technology with AI is implemented responsibly, prioritizing inclusiveness, fairness, transparency, security, and privacy.How artificial intelligence and machine learning could have a tangible impact on healthcare providers and patients, with the potential to augment and enhance the work of healthcare professionals.Resources:
Connect with and follow Mary on LinkedIn.Follow Nuance Communications on LinkedIn and visit their website. -
About Zane Burke:
Zane Burke is an internationally recognized healthcare IT leader. Burke has a clear, forward-looking vision for digital healthcare, a unique understanding of the challenges in global healthcare delivery, and a vision for how Quantum Health navigation can better the experience.
Burke is focused on creating great healthcare experiences for all and addressing the imbalances in healthcare delivery. At Quantum Health, he leads the consumer healthcare navigation and care coordination company in transforming the healthcare journey by “managing the hard stuff” for employee members and delivering validated claims savings for self-insured employer clients. His leadership drives more awareness of navigation and reaches new markets, ultimately serving more members and improving more lives.
Prior to joining Quantum Health, Burke served as chief executive officer of Silicon Valley-based Livongo Health, Inc., a leading software as a service (SaaS) consumer digital health company. He also spent more than two decades at Cerner Corporation, where he concluded his service as the company’s president. He serves on several corporate and nonprofit boards.
Things You’ll Learn:
Quantum Health's collaboration with Vanderbilt and the affiliated network is setting a new standard for healthcare navigation with a mission to revolutionize healthcare outcomes and provide high-quality networks and navigation solutions for self-insured employers.Digital transformation is reshaping healthcare delivery in 2024, with a focus on providing better member experiences and driving cost control to ensure better clinical outcomes and financial results.Quantum Health's commitment to using AI and ML technologies to improve the member experience and streamline processes, such as real-time intercept, to engage with members at crucial moments, leading to better engagement and rapport.Quantum Health acts as the connective tissue between a clicks and mortar world, amplifying the impact of value-based care.From leveraging health signals for real-time intercept to streamlining pre-authorizations, Quantum Health is using innovative tech to enhance the member experience and drive quality outcomes.Resources:
Connect with and follow Zane on LinkedIn.Learn more about Quantum Health on their LinkedIn and website. -
The healthcare system has lost its way in large part due to technological advancements, pulling clinicians away from patients to read electronic health records at a computer terminal.
But Dr. David Feinberg believes that technology has the potential to solve the problems it created and put doctors and nurses back in front of the people they serve.
So, what is Dr. Feinberg’s vision for the future of EHRs? How can we leverage patient data to improve quality of care for individual patients and the healthcare system in general?
Dr. David Feinberg is Chairman of Oracle Health, where he is committed to making healthcare more accessible, affordable and equitable.
Dr. Feinberg's work advances thought leadership and strategy related to unleashing the healing power of data through an open and connected healthcare ecosystem.
On this episode of The Beat, Dr. Feinberg joins host Dr. Gautam Gulati to explain how we might use advanced technologies to ‘get people to care about each other again.’
Dr. Feinberg explains why he measures time spent with patients versus time saved by technology and describes how to use the predictive capability of EHR data for better patient engagement.
Listen in for insight on leveraging social determinant information in EHRs to improve care and learn how Oracle is reimagining electronic health records to put clinicians back in front of their patients.
Topics Covered
Dr. Feinberg’s goals around making healthcare systems easier to navigateWhat Dr. Feinberg learned from running health systems at UCLA, Geisinger and GoogleHow Dr. Feinberg brings a commonsense approach to his role at OracleWhy Dr. Feinberg measures time with patients vs. time saved with technologyWhat inspired Dr. Feinberg’s idea to eliminate the waiting room and why it didn’t workHow investing in communities decreases the burden on our healthcare systemHow clinicians might use the social determinant information in Oracle’s EHRUsing the predictive capability of data in EHRs for better patient engagementDr. Feinberg’s open and connected approach to sharing data sets (with appropriate privacy measures and cybersecurity in place)How Dr. Feinberg thinks about mitigating the risks of someone misusing patient dataDr. Feinberg’s fear that we’ll use technology to worsen inequities in healthcareLeveraging advanced technologies to ‘get people to care about each other again’Connect with Dr. David Feinberg
Oracle HealthConnect with Dr. Gautam Gulati & Dr. Jessica Shepherd
ViVEHLTHDr. Shepherd on TwitterDr. Shepherd on LinkedInDr. Gulati on TwitterDr. Gulati on LinkedInResources
Oracle Clinical Digital Assistant -
About Scott Schell:
Dr. Schell is an accomplished senior executive, surgeon, and healthcare futurist with over 30 years of experience spanning the healthcare, biotech, and technology sectors both in the US and globally. His leadership roles have included CEO, CMO, Chair, Director, and Executive Consultant, and he brings an extensive background that includes healthcare delivery and operations, pharma, medical devices, clinical trials, and data science.
In his leadership roles, Dr. Schell has a proven track record of driving growth, improving operational performance, and creating transforming innovation, through a variety of diverse healthcare contexts. He leads the development and implementation of large-scale population health and predictive analytics platforms at organizations like Alere, the Cleveland Clinic, and UPMC. A serial entrepreneur, he has founded and exited five healthcare startups and served as Managing Partner for a private equity firm with a portfolio of digital health assets.
Things You’ll Learn:
Healthcare is undergoing a digital revolution, prioritizing patient experience, efficient call center operations, streamlined financial services, and enhanced access.AI and machine learning are pivotal in healthcare, boosting patient experiences, expediting authorizations, and optimizing operations.The healthcare industry must start digital transformation projects by identifying key solutions, embracing change management, and establishing an accountable leadership team.Dr. Scott warns against AI pitfalls like hallucination, offering tips for a robust transformation start.Dr. Scott stresses tech solutions, change management, and proactive leadership for successful automation.Resources:
Connect with and follow Scott Schell on LinkedIn.Follow Cognizant on LinkedIn and visit their website. -
About Ann Louise Puopolo:
Ann Louise is an accomplished and highly respected safety professional and has held many prestigious positions, including Vice President of Enterprise Patient Safety and the Enterprise PSO LLC at CVS Health (until her retirement in 2020) and Vice President of Patient Safety for CRICO (Risk Management Foundation of the Harvard Medical Institutions). More recently, she has been serving as the Chair of the RLDatix Customer Advisory Board since 2022.
She calls Boston, MA, home and is an active board member of many local healthcare organizations, including the Tufts Medicine Board of Directors’ Committee on the Quality of Care (since June 2021), Vice-chair at Tufts Medical Center Board of Directors’ Committee on the Quality of Care (since 2018), and the Board of Directors for the Alliance for Quality Improvement and Patient Safety - the trade organization to PSOs (since 2013).
Ann Louise has been a long-time collaborator with RLDatix. The relationship began while she was at CRICO, supporting the Harvard Medical School-affiliated institutions with their programs to mitigate risk and improve safety. When Ann Louise moved to CVS Health, she built out their patient safety program. She brought in RL6 to support their retail pharmacy, mail, specialty, infusion, long-term care pharmacies, and MinuteClinic needs.
Ann Louise received a Bachelor of Science in Nursing degree from Vanderbilt University and practiced as a critical care nurse at Boston’s Beth Israel Deaconess Hospital.
Things You’ll Learn:
The COVID-19 pandemic has accentuated the healthcare staffing crisis, but its roots go much deeper. Nurses, the backbone of the healthcare system, often take on more than necessary and are underutilized, contributing to burnout. Ann Louise underscores the potential of technology and data analytics to optimize workforce utilization and enhance patient outcomes.Ann Louise stresses the importance of integrating systems to improve efficiency, highlighting the critical role of data insights in informed decision-making for providers and healthcare organizations.Recognizing the significance of involving frontline healthcare professionals like nurses in decision-making, we can foster a culture of innovation and problem-solving within healthcare organizations by giving them a voice and acknowledging their contributions.Resources:
Connect with and follow Ann Louise on LinkedIn.Follow RLDatix on LinkedIn and visit their website.Reach out to Ann at [email protected] -
Innovation in healthcare exploded during the pandemic.
But many hospitals don’t have the infrastructure to take advantage of this emergent technology. And many people don’t have the devices or connectivity they need to manage their care.
So, how do we promote technological equity (also known as techquity)? How do we bridge the digital gap for underserved populations?
Gary Lynch is Global Practice Lead & CTO for Healthcare and Life Sciences at Verizon Business, where he manages a team of innovation principals, healthcare strategists and solution architects across the healthcare ecosystem.
Gary has over 20 years of experience leading transformation within the healthcare space, with a focus on accountable care, population health, revenue cycle, operations and business development.
On this episode of The Beat, recorded live at ViVE 2024, Gary joins hosts Dr. Jessica Shepherd and Dr. Gautam Gulati to discuss how telecom companies like Verizon will play a crucial role in the future of healthcare delivery.
Gary shares strategies for leveraging purpose-built technology to make healthcare more proactive and improve patient engagement in the process.
Listen in for Gary’s insight on providing access to care in non-traditional settings and learn how Verizon is partnering with UC Davis Health to improve health outcomes via tech equity!
Topics Covered
Why telecom companies will play a big part in the future of healthcare deliveryGary’s quadruple aim of improving health outcomes, lowering costs and improving the patient and clinician experienceHow Gary thinks about keeping pace with expanding points of access to healthcareGary’s take on the third-party payment system in healthcareVerizon’s partnership with UC Davis to promote health equity via digital inclusionGary’s strategies for leveraging technology to make healthcare proactiveHow Verizon is improving access to care through purpose-built techImproving the patient experience and engagement by way of gamificationHow innovation in the healthcare space accelerated during COVIDVerizon’s aim to help hospitals build the infrastructure to take advantage of emergent techConnect with Gary Lynch
Health Care IT & Digital Solutions at VerizonGary on LinkedInConnect with Dr. Gautam Gulati & Dr. Jessica Shepherd
ViVEHLTHDr. Shepherd on TwitterDr. Shepherd on LinkedInDr. Gulati on TwitterDr. Gulati on LinkedInResources
Heartbreak in the HeartlandVerizon’s Partnership with UC Davis HealthAffordable Connectivity ProgramMedivis -
About Dave Sohigian:
Dave Sohigian is the CTO at Large at Workday and is tasked with helping customers get the most out of Workday. He is part of the Global Office of the CTO, responsible for communicating Workday’s strategy to customers and prospects, and informing the development organization about market needs to influence future innovation. Dave joined Workday 14 years ago and most recently served as Global CTO. Prior to joining Workday, he held a number of development and technical consulting roles and joined the organization as Principal Enterprise Architect. Dave holds a BSc degree in Fermentation Science from the University of California, Davis.
Things You’ll Learn:
AI and ML are key in reshaping healthcare delivery in 2024, with the potential to improve patient care and outcomes significantly.Organizations must address critical issues of data security and privacy by emphasizing transparency, regular reviews of data usage, and a human-in-the-loop approach to AI and ML.Workday's dedication to incorporating a human element in AI and ML applications ensures that judgment remains a vital component in decision-making processes.Workday focuses on delivering solutions that benefit their customers in specific areas like human resources, financials, and payroll, all powered by AI rather than focusing solely on direct AI sales.Dave stresses the importance of establishing a clear goal and strategy for digital transformation in healthcare delivery rather than being solely driven by fear or competition.Resources:
Connect with and follow David on LinkedIn.Follow Workday on LinkedIn and visit their website. -
About Jonathan Machado:
Jonathan Machado is the Managing Director of Samsung Next, which is Samsung Electronics' venture capital arm. He is in charge of making investments in health tech. He has helped Samsung Next participate in many businesses, such as BigHealth, Healthy.io, Huma Therapeutics, Lark, Elvie, and DayTwo.
Jonathan worked as an investor and partner at Jerusalem Venture Partners for five years before joining Samsung Next in 2018. There, he focused on early-stage Israeli startups. Besides that, he has an MBA from The Hebrew University of Jerusalem.
Jonathan was born and raised in Jerusalem. He and his family just moved to the New York metropolitan area.
Things You’ll Learn:
Samsung Next adopts a unique VC model with "no proof," fostering a collaborative environment with entrepreneurs.Success stories like LoopPay and SmartThings demonstrate Samsung NEXT's strategic investments that align with long-term corporate goals.Samsung's healthcare vision involves enabling users to own their health records, creating a paradigm shift in personal healthcare management.Soon, Samsung Health’s tens of millions of users will be able to own their records and begin a journey of owning their health care through these records.Samsung Next measures success through regular VC metrics, emphasizing ROI and influencing strategic decisions within the company.Resources:
Connect with and follow Jonathan Machado on LinkedIn.Follow Samsung Next on LinkedIn and visit their website. -
About Mark Frank:
Mark Frank is the CEO and Co-founder of SonderMind, leading a rapidly expanding and compassionate team dedicated to reshaping behavioral health. His mission is to enhance access, broaden utilization, and elevate clinical outcomes in this field. Mark believes in transparent, empathetic, and courageous leadership, aspiring to build an organization that leaves a positive and transformative impact on behavioral health and the broader healthcare ecosystem.
Before founding SonderMind in 2015, Mark played a pivotal role in establishing three other successful ventures, including Next Oncology, TermScout, and SafeImageMD. His entrepreneurial journey follows a background in healthcare investment banking at Morgan Stanley, Lehman Brothers, and CDI Global, coupled with military service as an officer in the US Army.
With degrees in Computer Science, Computer Information Systems, Engineering Management, and an MBA in Finance and Operations, Mark's commitment stems from personal experiences, witnessing the challenges faced by friends and colleagues in accessing mental health care after military deployments.
Things You’ll Learn:
AI helps personalize care pathways for patients and assists providers in delivering the highest quality care efficiently.The world is in a mental health crisis. Competition and innovation are crucial to solving this massive problem.Mental health care is not discretionary. It has an immense impact on physical health and overall well-being.Engage patients through various channels, including employers, health systems, payers, and consumers.SonderMind serves as a mental health home, providing comprehensive digital tools for sustained well-being.Resources:
Connect with and follow Mark Frank on LinkedIn.Follow SonderMind on LinkedIn and visit their website. -
About Vijay Kedar:
Vijay Kedar, co-founder and CEO of Tomorrow Health, was raised in a family of physicians, often joking that he was “pre-med coming out of the womb.” However, it wasn’t until he took on managing his mother's care through stage III colorectal cancer and acute respiratory distress syndrome that the idea for Tomorrow Health was born. In this episode, Kedar speaks with host Steve Krupa about using technology to coordinate high-quality home-based care for patients and families who find securing such care increasingly difficult to navigate.
Kedar also discusses how home-based care improves health outcomes, alleviates the administrative and healthcare burden for providers, and is often the most economical option for patients requiring long-term treatment. He says, “Treating a patient with the same conditions at home can be one-tenth the cost of doing so in a hospital-based setting and one-third the cost of doing so in a post-acute setting like a skilled nursing facility.” Kedar goes on to outline how Tomorrow Health’s launch during the pandemic essentially changed how home-based care was ordered, delivered, and purchased to meet an ever-growing demand.
Things You’ll Learn:
Tomorrow Health emphasizes the use of technology and strategic partnerships to enhance the efficiency of coordinating and delivering home-based healthcare.Tomorrow Health’s commitment aims to provide patients and families across the nation with more dependable and higher-quality care.Vijay highlighted the significance of tackling distinct challenges faced by different stakeholders in the home-based care ecosystem.Through aligning incentives and consistently offering value propositions, Tomorrow Health is expediting the acquisition, engagement, and retention of stakeholders. This strategic approach is paving the way for widespread market adoption.Tomorrow Health is utilizing the capabilities of artificial intelligence to automate operational processes, diminish manual workload, and expedite the delivery of home-based care to patients.Resources:
Connect with and follow Vijay Kedar on LinkedIn.Follow Tomorrow Health on LinkedIn.Visit the Tomorrow Health website here. -
Research has shown that less than 10% of longevity is based on genetics and 90% hinges on your lifestyle choices.
But if you don’t have Bryan Johnson’s resources, how do you identify the gap between your chorological age versus your real age?
And more importantly, how do you use that information to design a plan that will truly move the needle on helping you live healthier, longer?
Melanie Goldey is CEO of Tally Health, a biotech company developing science-backed tools for consumers to increase health span and extend longevity.
Melanie has an extensive background in technology and healthcare startups, and she is passionate about making longevity science accessible to consumers.
On this episode of The Beat, Melanie joins host Dr. Gautam Gulati to discuss the future of diagnostic markers and testing to optimize for the extension of both lifespan and health span.
Melanie explains how Tally Health differs from prior iterations of real age measurement and describes how her team uses DNA methylation to develop personalized recommendations for its members.
Listen in to understand the benefits of Tally Helth’s pro-longevity supplements and learn how to enhance longevity with small improvements to your diet, fitness, sleep, mental health and habits!
Topics Covered
How Tally Health is working to help consumers live healthier, longerThe 3 components of Tally Health’s consumer longevity offeringWhat differentiates Tally from prior iterations of real age measurementHow Tally uses DNA methylation to develop personalized recommendationsDavid Sinclair’s research on epigenetics and his information theory of agingHow much of longevity is based on genetics vs. lifestyle choicesHow Melanie thinks about quick fixes vs. small lifestyle adjustmentsThe benefits of Tally Health’s pro-longevity supplementsHow machine learning can improve specificity of Tally’s recommendationsThe connections among diet, fitness, sleep, mental health and habitsWhat we might learn from Bryan Johnson’s biohacking experiencesOther markers Tally Health is studying (beyond DNA methylation)Connect with Melanie Goldey
Tally HealthMelanie on LinkedInConnect with Dr. Jessica Shepherd & Dr. Gautam Gulati
HLTHDr. Shepherd on XDr. Shepherd on LinkedInDr. Gulati on XDr. Gulati on LinkedInResources
Harvard Aging LabDavid Sinclair’s Landmark Study on Longevity in NatureBryan Johnson -
In this groundbreaking era of healthcare, the opportunity to revolutionize cancer outcomes has never been more promising. With cutting-edge testing techniques, early detection strategies, and the power of AI, the landscape of cancer care is evolving to save lives and enhance patient well-being like never before.
In this episode of The Beat, Dr. Gautam Gulati sits down with Dr. Megan Hall to discuss the future of cancer detection and prevention through early genetic testing.
The significance of early detection in cancer careThe role of DNA methylation in cancer detectionThe importance of evaluating the accuracy of cancer screening and the power of positive predictive valueThe need for education across the cancer care continuumThe potential for healthcare cost savings with early cancer detectionThe role of AI and machine learning in cancer detectionGRAIL's focus on expanding access to cancer screening and its plans for future products
Dr. Megan Hall is the Vice President of Corporate Affairs at GRAIL. With a Ph.D. in microbiology, immunology, and molecular genetics she is dedicated to making early cancer detection and prevention accessible on a population scale.
As Dr. Hall says, “I was enamored of the mission to detect cancer early when it can be cured. That's a huge problem that we have to be frank have not made great headway on in the 50 years that we've been waging this war on cancer.”
Now she shares how GRAIL's flagship product, Galleri, is using advanced technology, including DNA methylation analysis and artificial intelligence (AI), to detect and predict cancer in a non-invasive way.
Listen in as we explore the potential cost savings and improved outcomes with early cancer detection, and GRAIL's efforts to make this transformative technology accessible to a broader population.
Topics CoveredConnect with Dr. Megan Hall
Dr. Hall on LinkedInConnect with Dr. Gautam Gulati & Dr. Jessica Shepherd
HLTHDr. Gulati on XDr. Gulati on LinkedInDr. Jessica Shepherd MDDr. Shepherd on XResources
GRAILGalleri Test - GRAIL -
How can we transform healthcare delivery to better serve ALL people and communities?
In today's episode of The Beat, host Dr. Gautam Gulati welcomes special guest Dr. Marc Harrison, a Partner at General Catalyst and the Founding Partner of the new company owned by General Catalyst called Health Assurance Transformation Corporation, HATCo.
Dr. Marc Harrison is a distinguished healthcare leader with a career dedicated to improving health equity. His journey spans from a pediatric intensivist to an entrepreneurial path. Dr. Harrison's latest venture, HATCo focuses on reshaping healthcare systems to embrace digital, value-based care while preserving local community identity.Dr. Harrison walks listeners through how the pandemic exacerbated the fragility of the healthcare system, and why NOW is the time to address the social determinants of health and holistic patient care. He also discusses HATCo's unique approach, advisory services, and its ecosystem of partner health systems.
Listen in to explore the challenges and opportunities in transitioning from a volume-based healthcare system to one that truly values patient outcomes and health equity and how HATCo's insights and innovative solutions could reshape the healthcare landscape.
The importance of addressing social determinants of healthThe shift from volume-based care to value-based careThe impact of the COVID-19 pandemic on the healthcare system and the need for healthcare systems to become more resilient and adaptableThe role of innovation and digital tools in healthcare transformationHATCo's mission to create a better healthcare system and improve public health outcomesThe challenges and opportunities in modernizing healthcare delivery
Topics CoveredConnect with Dr. Marc Harrison
Dr. Marc Harrison on LinkedInConnect with Dr. Gautam Gulati & Dr. Jessica Shepherd
HLTHDr. Gulati on XDr. Gulati on LinkedInDr. Jessica Shepherd MDDr. Shepherd on XResources
General CatalystThe Future of Health: A Bold Leap Forward | General Catalyst -
About Kelly Bliss:
Kelly Bliss is president of U.S. Group Health. She oversees sales, client management, and client and commercial operations for the business.
Ms. Bliss has strong expertise in creating cohesive client-focused organizations. Most recently, she held the position of chief client officer at Teladoc Health. Under her leadership, client services achieved record growth and retention through a focus on delivering value and a best-in-class experience to our clients. Ms. Bliss also built and managed high-functioning, global teams at companies such as Best Doctors and InterSystems. At Best Doctors, she served as chief of staff, leading the organization's key strategic growth initiatives until the eventual acquisition by Teladoc Health in 2017.
Ms. Bliss was recognized as one of the Top 25 Women Leaders in Healthcare Software of 2020 by The Healthcare Technology Report and serves as executive sponsor for the Teladoc Health Women's Network. She holds a bachelor's degree in industrial psychology from Nichols College.
Things You’ll Learn:
Teladoc places a priority on well-rounded growth, giving significant attention to both revenue and profitability.This commitment is supported by a robust balance sheet and substantial investments in research and development.The growing significance of hyper-personalized member experiences and the utilization of multiple artificial intelligence models to enhance outcomes for clients and members.Kelly Bliss's professional odyssey as a "code breaker" involves challenging norms and assembling unconventional teams to optimize and create high-performance team dynamics.The surge of virtual care is evident, with Teladoc's research indicating a growing trend among employers investing in comprehensive virtual care providers.Resources:
Connect with and follow Kelly Bliss on LinkedIn.Follow Teladoc on LinkedIn and visit their website. -
How do you inspire a community to take ownership of their health?
If you ask Kristen Cerf, the secret lies in hiring staff from the community you serve and connecting people with the resources they need to improve their health.
Kristen is President and CEO of Blue Shield of California Promise Health Plan, where she is responsible for ensuring access to quality care for Blue Shield Promise’s 530,000 Medi-Cal members in Los Angeles and San Diego counties.
Under Kristen’s guidance, Blue Shield Promise has delivered several initiatives improving access to and availability of person-centered care to California's underinsured, low income and medically underserved populations.
On this episode of The Beat, Kristen joins host Dr. Jessica Shepherd to discuss the future of grassroots efforts to promote health care in the community.
Kristen explains how Blue Shield Promise helps members navigate the complexities of the Medi-Cal system, leveraging community health advocates to build health literacy and improve patient outcomes.
Listen in for insight using data to provide support based on need and learn how Kristen’s team works with providers, community-based organizations and other nonprofits to better serve Blue Shield Promise members.
Topics Covered
How being a nonprofit organization benefits Blue Shield of California Promise Health PlanWhy a grassroots approach inspires communities to take ownership of their healthHow Blue Shield Promise helps members navigate the complexities of the Medi-Cal systemHow Blue Shield Promise’s community health advocates work with providers to improve outcomesWhy so few grassroots community health programs exist in the USHow Kristen’s team uses data to deliver support based on needHow Kristen thinks about translating information obtained from Blue Shield Promise members into dataHow Kristen’s team gets feedback from providers re: Blue Shield Promise patient outcomesWhy Kristen sites the Blue Shield Promise street medicine program among her greatest accomplishmentsConnect with Kristen Cerf
Blue Shield of California Promise Health PlanKristen on LinkedInConnect with Dr. Jessica Shepherd & Dr. Gautam Gulati
HLTHDr. Shepherd on XDr. Shepherd on LinkedInDr. Gulati on XDr. Gulati on LinkedInResources
California Advancing & Innovating Medi-CalCalifornia Primary Care Association Annual ConferenceBlue Shield Promise Community Health Centers - Se mer
